The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 15,276,000 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
ABCELLERA BIOLOGICS INC | COM | 00288U106 | 5,183,809 | 1,126,915 | SH | SOLE | 1,126,915 | 0 | 0 | ||
ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | 43,441,734 | 500,827 | SH | SOLE | 500,827 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 20,965,629 | 118,383 | SH | SOLE | 118,383 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 25,486,144 | 2,095,900 | SH | SOLE | 2,095,900 | 0 | 0 | ||
ARCELLX, INC. | COMMON STOCK | 03940C100 | 38,571,000 | 1,075,000 | SH | SOLE | 1,075,000 | 0 | 0 | ||
APPLE INC | COM | 037833100 | 37,916,167 | 221,460 | SH | SOLE | 221,460 | 0 | 0 | ||
ASML HOLDING N V | N Y REGISTRY SHS | N07059210 | 116,413,402 | 197,760 | SH | SOLE | 197,760 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 35,392,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 26,365,500 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
BROOKFIELD ASSET MANAGMT LTD | CL A LMT VTG SHS | 113004105 | 20,911,081 | 627,207 | SH | SOLE | 627,207 | 0 | 0 | ||
BROOKFIELD CORP | CL A LTD VT SH | 11271J107 | 121,334,792 | 3,880,230 | SH | SOLE | 3,880,230 | 0 | 0 | ||
CABLE ONE INC | COM | 12685J105 | 72,893,623 | 118,403 | SH | SOLE | 118,403 | 0 | 0 | ||
CORCEPT THERAPEUTICS INC | COM | 218352102 | 92,044,178 | 3,377,768 | SH | SOLE | 3,377,768 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 32,714,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 23,356,828 | 1,566,521 | SH | SOLE | 1,566,521 | 0 | 0 | ||
CYTEIR THERAPEUTICS INC | COM | 23284P103 | 1,920,916 | 676,379 | SH | SOLE | 676,379 | 0 | 0 | ||
DISC MEDICINE, INC. | COM | 254604101 | 51,244,485 | 1,090,772 | SH | SOLE | 1,090,772 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 34,790,858 | 6,071,703 | SH | SOLE | 6,071,703 | 0 | 0 | ||
GALECTO INC | COM | 36322Q107 | 1,798,410 | 2,497,791 | SH | SOLE | 2,497,791 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 33,817,426 | 1,339,304 | SH | SOLE | 1,339,304 | 0 | 0 | ||
INSPIRE MED SYS INC | COM | 457730109 | 11,906,400 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
IO BIOTECH INC | COM | 449778109 | 8,103,364 | 5,747,067 | SH | SOLE | 5,747,067 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 1,141,990 | 815,707 | SH | SOLE | 815,707 | 0 | 0 | ||
LANZATECH GLOBAL INC | COM | 51655R101 | 73,855,326 | 15,814,845 | SH | SOLE | 15,814,845 | 0 | 0 | ||
LAVA THERAPEUTICS NV | SHS | N51517105 | 3,528,000 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
MARQETA INC | CLASS A COM | 57142B104 | 2,640,517 | 441,558 | SH | SOLE | 441,558 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 47,400,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
PHARVARIS N V | COM | N69605108 | 27,743,013 | 1,329,325 | SH | SOLE | 1,329,325 | 0 | 0 | ||
RALLYBIO CORP | COM | 75120L100 | 7,373,557 | 2,187,999 | SH | SOLE | 2,187,999 | 0 | 0 | ||
RENEO PHARMACEUTICALS INC | COM | 75974E103 | 25,344,169 | 3,330,377 | SH | SOLE | 3,330,377 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 20,510,490 | 1,001,000 | SH | SOLE | 1,001,000 | 0 | 0 | ||
SALESFORCE.COM, INC. | COM | 79466L302 | 107,574,790 | 530,500 | SH | SOLE | 530,500 | 0 | 0 | ||
SEAGEN INC. | COM | 81181C104 | 33,941,030 | 159,986 | SH | SOLE | 159,986 | 0 | 0 | ||
SILK RD MED INC | COM | 82710M100 | 5,004,921 | 333,884 | SH | SOLE | 333,884 | 0 | 0 | ||
SPERO THERAPEUTICS INC | COM | 84833T103 | 567,371 | 468,902 | SH | SOLE | 468,902 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 15,192,479 | 6,722,336 | SH | SOLE | 6,722,336 | 0 | 0 | ||
TAIWAN SEMICONDUCTOR MFG LTD | SPONSORED ADS | 874039100 | 61,766,782 | 710,780 | SH | SOLE | 710,780 | 0 | 0 | ||
TREACE MED CONCEPTS INC | COM | 89455T109 | 4,719,600 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 43,078,100 | 845,000 | SH | SOLE | 845,000 | 0 | 0 |